Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roxadustat in Hemodialysis Patients (DENALI)
NCT04410198Phase 3Completed
- Sponsor
- FibroGen
- Start
- May 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of roxadustat in anemia of chronic kidney disease, sponsored by FibroGen. Started May 2020; status: completed.
02
Drugs
roxadustat
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on NCT04410198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04410198.